v3.25.1
Exclusive License Agreement (MDB Minnesota One) (Details Narrative)
3 Months Ended
Mar. 31, 2025
USD ($)
shares
Phase II clinical [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Payments for licensed products $ 250,000
Phase III clinical [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Payments for licensed products 1,500,000
New Drug Application First [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Payments for licensed products 2,000,000
New Drug Application [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Payments for licensed products $ 5,000,000
License Agreement [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Issuance of shares | shares 1,980,000
License fee $ 150,000